Trans-fatty acids in New Zealand patients with coronary artery disease

European Journal of Preventive Cardiology

Volumn 18, Issue 4, 2011, Pages 615-620

  Benatar, Jocelyne R ^a   Gladding, Patrick ^a   White, Harvey d ^a   Zeng, Irene ^a   Stewart, Ralph Ah ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

CRP; polyvascular disease; Trans fatty acids

Indexed keywords

C REACTIVE PROTEIN; HYDROGENATED VEGETABLE OIL; TRANS FATTY ACID;

AGED; ANIMAL PRODUCT; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHROMATOGRAPHY, GAS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DAIRY PRODUCTS; DIETARY FATS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEAT; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW ZEALAND; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRANS FATTY ACIDS;

EID: 80054848264     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/1741826710389415     Document Type: Article

References (26)

1. The American Oil Chemists' Society. Lipid Chemistry, Biology, Technology & Analysis – 2010, http://lipidlibrary.aocs.org accessed July 2010.
2. Sun Q, Ma J, Campos H and Hu FB. Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. Am J Clin Nutr 2007; 86: 929–937.
3. Jakobsen MU, Bysted A, Andersen NL, et al. Intake of ruminant trans fatty acids and risk of coronary heart disease – an overview. Atheroscler Suppl 2006; 7: 9–11.
4. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180–9.
5. Lemaitre RN, King IB, Mozaffarian D, et al. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation 2006; 114: 209–215.
6. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ and Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med 2006; 354: 1601–1613.
7. Sun Q, Ma J, Campos H, et al. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 2007; 115: 1858–1865.
8. Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993; 341: 581–585.
9. Oomen CM, Ocke MC, Feskens EJ, Erp-Baart MA, Kok FJ and Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001; 357: 746–751.
10. Food Standards Australia New Zealand FSANZ. Review Report – Trans Fatty Acids in the Australia and NZ Food Supply 2009, http://www.foodstandards.gov.au accessed July 2010.
11. Thygesen K, Alpert JS and White HD. Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525–2538.
12. Sabatine MS, Morrow DA, Jablonski KA, et al. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 2007; 115: 1528–1536.
13. Harris WS, Reid KJ, Sands SA and Spertus JA. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 2007; 99: 154–158.
14. Hodson L, Skeaff CM and Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008; 47: 348–380.
15. Mozaffarian D, Rimm EB, King IB, Lawler RL, McDonald GB and Levy WC. Trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr 2004; 80: 1521–1525.
16. Booker CS and Mann JI. Trans fatty acids and cardiovascular health: translation of the evidence base. Nutr Metab Cardiovasc Dis 2008; 18: 448–456.
17. Huth PJ. Do ruminant trans fatty acids impact coronary heart disease risk? Lipid Technol 2007; 19: 59–62.
18. Laine DC, Snodgrass CM, Dawson EA, Ener MA, Kuba K and Frantz Jr ID. Lightly hydrogenated soy oil versus other vegetable oils as a lipid-lowering dietary constituent. Am J Clin Nutr 1982; 35: 683–690.
19. Baer DJ, Judd JT, Clevidence BA and Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004; 79: 969–973.
20. Lopez-Garcia E, Schulze MB, Meigs JB, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005; 135: 562–566.
21. Zeleniuch-Jacquotte A, Chajes V, Van Kappel AL, Riboli E and Toniolo P. Reliability of fatty acid composition in human serum phospholipids. Eur J Clin Nutr 2000; 54: 367–372.
22. Jakobsen MU, Overvad K, Dyerberg J and Heitmann BL. Intake of ruminant trans fatty acids and risk of coronary heart disease. Int J Epidemiol 2008; 37: 173–182.
23. Engelfriet P, Hoekstra J, Hoogenveen R, Buchner F, van Rossum C and Verschuren M. Food and vessels: the importance of a healthy diet to prevent cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2010; 17: 50–55.
24. Jakobsen MU, Overvad K, Dyerberg J, et al. Intake of ruminant trans fatty acids and risk of coronary heart disease. Int J Epidemiol 2008; 37: 173–182.
25. Engelfriet P, Hoekstra J, Hoogenveen R, et al. Food and vessels: the importance of a healthy diet to prevent cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2010; 17: 50–55.
26. Zeleniuch-Jacquotte A, Chajes V, Van Kappel AL, et al. Reliability of fatty acid composition in human serum phospholipids. Eur J Clin Nutr 2000; 54: 367–372.